Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Guanfacine on Opioid-induced Hyperalgesia and Tolerance
NCT01681264Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2014
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in chronic pain, sponsored by Massachusetts General Hospital. Started Sep 2014; status: terminated.
02
Drugs
guanfacine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01681264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681264.